Company news

Hitgen Inc. news in 2025

Hitgen Inc.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Completion of Non-trading Transfer under the 2025 Employee Stock Ownership Plan

December 26, 2025

Announcement on Outward Investment

December 19, 2025

HitGen Submits Commitment Letter to Science Based Targets initiative (SBTi)

December 15, 2025

Announcement on Results of Shareholding Reduction by Shareholder Lhasa Economic and Technological Development Zone Huabo Medical Equipment Co., Ltd.

November 24, 2025

HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases

November 20, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

November 14, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 10, 2025

Report for Q3 2025

October 29, 2025

HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor

September 15, 2025

Board of Supervisors' Verification Opinions and Publicity Explanation on List of Proposed Incentive Objects in 2025 Restricted Stock Incentive Plan

September 8, 2025

Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale

September 4, 2025

Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0

August 27, 2025

Announcement on Abnormal Fluctuations in Stock Trading

July 21, 2025

ESG | HitGen Releases Its Inaugural Sustainability Report

July 4, 2025

Indicative Announcement on Terminating Major Asset Restructuring

June 29, 2025

Indicative Announcement on Changes in Equity of Shareholder with Over 5% Shares and Results of Shareholding Reduction

June 23, 2025

Announcement on Result of Share Reduction by Shareholder Huabo Medical Device Co., Ltd., Lhasa Economic and Technological Development Zone

June 19, 2025

Announcement on Providing Guarantee for Wholly-owned Subsidiary

June 18, 2025

Announcement on Implementation of Dividend Distribution for 2024

June 11, 2025

Announcement on Progress in Planning Major Asset Restructuring

May 29, 2025

Indicative Announcement on Equity Change of Shareholder Anji Dongfang Jiayu Enterprise Management Partnership (Limited Partnership) with Over 5% Shares Reaching 1% Scale

May 26, 2025

Indicative Announcement on Postponing Term Change of the Board of Directors and the Board of Supervisors and Proposing Resignation by Independent Director upon Expiration of Term

May 23, 2025

Announcement on Share Increase Plan of Ningbo Juzhi Pioneer Biotechnology Partnership Enterprise (Limited Partnership)

May 22, 2025

2024 Annual Report

April 25, 2025

Indicative Announcement on Planning Major Asset Restructuring and Signing Letter of Intent for Equity Acquisition

March 31, 2025

Announcement on Share Reduction Plan for Shareholders

March 2, 2025

Announcement on Preliminary Earnings Estimate for 2024

February 27, 2025

Announcement on Shareholding Reduction Results for Shareholder Chongqing Boyi Xintian Equity Investment Fund Partnership (L.P.)

February 14, 2025